Prostate News Archive
09-Sep-2006
Active Biotech publishes pre-clinical data regarding the TASQ prostate cancer project (SYS-CON Media)
Active Biotech (ACTI.ST) publishes a new scientific paper -'Identification of ABR-215050 as lead second generationquinoline-3-carboxamide anti-angiogenic agent for the treatment ofprostate cancer' - in the next issue of the scientific journal'prostate' (pre-available as an e-publication at NCBI National Centerfor Biotechnology, http://www.ncbi.nlm.nih.gov/) in collaborationwith Professor John T. 'Cycling helps me fight cancer' (BBC News)
A prostate cancer tells how exercise helped him to fight the disease. New Island Hospital to host free prostate cancer health lecture (Massapequa Post)
New Island Hospital, Hempstead Turnpike, Bethpage is presenting a free community health lecture on the topic of prostate cancer presented by Deepak Kapoor M.D. a urologist on staff at New Island Hospital. The lecture will be held on Monday September 18, 7 p.m. in the Staff Room located on the lower Got prostate question? Call hotline Saturday (Deseret Morning News)
Prostate cancer, from risk factors to early detection and treatment options, will be the topic of the Deseret Morning News/Intermountain Healthcare Hotline Saturday from 10 a September is prostate cancer awareness month! (The Prairie Advocate)
Recently, it was noted that cancer has passed heart disease as the number one cause of death in American adults. Prostate cancer is second only to lung cancer in annual cancer deaths of U.S. men. More Than Half of Survey Respondents Said They Are Concerned With the Accuracy of Prostate Cancer Screening Tests (PR Newswire via Yahoo! Finance)
A Harris Interactive survey conducted in July 2006 of 1,000 males age 45 to 70 years found that more than half of men are concerned with the accuracy of prostate cancer screening tests. September is Prostate Cancer Awareness Month (This Ithaca Journal)
One in six American men will get prostate cancer. And the good news is that most of them will survive; BUT this requires early diagnosis. My early diagnosis earlier this year allows me to call myself a cancer survivor. Active Biotech publishes pre-clinical data regarding the TASQ prostate cancer project (Market Wire via Yahoo! Finance)
Active Biotech publishes a new scientific paper - "Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer" - in the next issue of the scientific journal "Prostate" in collaboration with Professor John T. Prostate screenings urged (Deseret Morning News)
Although prostate cancer is very treatable when detected early, an estimated 27,000 American men will die from it this year. And nearly a quarter million will be diagnosed with the condition as well.
Back to Prostate News Archive
